Susquehanna Fundamental Investments, LLC Genetic Technologies LTD Transaction History

Susquehanna Fundamental Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.0 - $0.01 $0 - $361	-36,172 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$0.0 - $0.02 $0 - $568	-28,428 Reduced 44.01%	36,172 $154,000
Q2 2020 Aug 14, 2020	BUY	$0.0 - $0.0 $0 - $0	64,600 New	64,600 $147,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $11.9M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.